Core Viewpoint - Guangzhou Yinnuo Pharmaceutical Group Co., Ltd. has received a notice for the registration of its overseas issuance and listing, indicating a significant step towards its planned public offering in Hong Kong [1][3]. Group 1 - The company plans to issue up to 69,043,500 overseas listed ordinary shares and list them on the Hong Kong Stock Exchange [3]. - A total of 45 shareholders intend to convert their combined 383,729,000 unlisted shares into overseas listed shares for trading on the Hong Kong Stock Exchange [5]. - The company is required to report any major events to the China Securities Regulatory Commission (CSRC) from the date of the notice until the completion of the overseas issuance and listing [5][6]. Group 2 - The company must update its registration materials if it does not complete the overseas issuance and share conversion within 12 months from the date of the notice [6]. - The notice confirms the registration of the company's overseas issuance and "full circulation" of shares but does not imply any judgment or guarantee regarding the investment value or returns for investors [6].
速递｜又一国产GLP-1！银诺医药获香港上市备案通知书，拟发行不超过6904.35万股
GLP1减重宝典·2025-06-07 07:50